123 related articles for article (PubMed ID: 12836307)
1. Construction of the dual-functional RNA ligand against HCV NS3 protease and helicase.
Fukuda K; Sekiya S; Kikuchi K; Funaji K; Kuno A; Hasegawa T; Nishikawa S
Nucleic Acids Res Suppl; 2001; (1):147-8. PubMed ID: 12836307
[TBL] [Abstract][Full Text] [Related]
2. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
[TBL] [Abstract][Full Text] [Related]
3. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HCV NS3 protease by RNA aptamers in cells.
Nishikawa F; Kakiuchi N; Funaji K; Fukuda K; Sekiya S; Nishikawa S
Nucleic Acids Res; 2003 Apr; 31(7):1935-43. PubMed ID: 12655010
[TBL] [Abstract][Full Text] [Related]
5. Specific RNA aptamers to NS3 protease domain of hepatitis C virus.
Fukuda K; Vishinuvardhan D; Sekiya S; Kakiuchi N; Shimotohno K; Kumar PK; Nishikawa S
Nucleic Acids Symp Ser; 1997; (37):237-8. PubMed ID: 9586087
[TBL] [Abstract][Full Text] [Related]
6. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase.
Zhang C; Cai Z; Kim YC; Kumar R; Yuan F; Shi PY; Kao C; Luo G
J Virol; 2005 Jul; 79(14):8687-97. PubMed ID: 15994762
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease.
Fukuda K; Vishnuvardhan D; Sekiya S; Hwang J; Kakiuchi N; Taira K; Shimotohno K; Kumar PK; Nishikawa S
Eur J Biochem; 2000 Jun; 267(12):3685-94. PubMed ID: 10848986
[TBL] [Abstract][Full Text] [Related]
9. In vitro selection of RNA aptamers against the HCV NS3 helicase domain.
Nishikawa F; Funaji K; Fukuda K; Nishikawa S
Oligonucleotides; 2004; 14(2):114-29. PubMed ID: 15294075
[TBL] [Abstract][Full Text] [Related]
10. Analysis of interaction between RNA aptamer and protein using nucleotide analogs.
Sekiya S; Fukuda K; Hwang J; Kakiuchi N; Taira K; Kusakabe I; Nishikawa S
Nucleic Acids Symp Ser; 2000; (44):163-4. PubMed ID: 12903319
[TBL] [Abstract][Full Text] [Related]
11. The RNA-unwinding activity of hepatitis C virus non-structural protein 3 (NS3) is positively modulated by its protease domain.
Gu B; Pruss CM; Gates AT; Khandekar SS
Protein Pept Lett; 2005 May; 12(4):315-21. PubMed ID: 15907174
[TBL] [Abstract][Full Text] [Related]
12. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling of Protease
Zheng F; Lu G; Li L; Gong P; Pan Z
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835495
[TBL] [Abstract][Full Text] [Related]
14. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.
Yao N; Reichert P; Taremi SS; Prosise WW; Weber PC
Structure; 1999 Nov; 7(11):1353-63. PubMed ID: 10574797
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside triphosphatase and RNA helicase activities associated with GB virus B nonstructural protein 3.
Zhong W; Ingravallo P; Wright-Minogue J; Skelton A; Uss AS; Chase R; Yao N; Lau JY; Hong Z
Virology; 1999 Sep; 261(2):216-26. PubMed ID: 10497107
[TBL] [Abstract][Full Text] [Related]
16. The RNA aptamer-binding site of hepatitis C virus NS3 protease.
Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Shimotohno K; Taira K; Kusakabe I; Nishikawa S
Biochem Biophys Res Commun; 2000 Dec; 279(2):557-62. PubMed ID: 11118325
[TBL] [Abstract][Full Text] [Related]
17. N-Naphthoyl-substituted indole thio-barbituric acid analogs inhibit the helicase activity of the hepatitis C virus NS3.
Marecki JC; Aarattuthodiyil S; Byrd AK; Penthala NR; Crooks PA; Raney KD
Bioorg Med Chem Lett; 2019 Feb; 29(3):430-434. PubMed ID: 30578035
[TBL] [Abstract][Full Text] [Related]
18. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
Liu D; Wang YS; Gesell JJ; Wyss DF
J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
[TBL] [Abstract][Full Text] [Related]
19. The interdomain interface in bifunctional enzyme protein 3/4A (NS3/4A) regulates protease and helicase activities.
Aydin C; Mukherjee S; Hanson AM; Frick DN; Schiffer CA
Protein Sci; 2013 Dec; 22(12):1786-98. PubMed ID: 24123290
[TBL] [Abstract][Full Text] [Related]
20. Novel ATP-independent RNA annealing activity of the dengue virus NS3 helicase.
Gebhard LG; Kaufman SB; Gamarnik AV
PLoS One; 2012; 7(4):e36244. PubMed ID: 22558403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
